» Articles » PMID: 10952246

Pathomorphologic Study on the Mechanism of Fatty Change in Small Hepatocellular Carcinoma of Humans

Overview
Journal J Hepatol
Publisher Elsevier
Specialty Gastroenterology
Date 2000 Aug 22
PMID 10952246
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: Fatty change is frequently observed in small hepatocellular carcinoma (HCC) of the early stage. However, the mechanism of fatty change and its pathomorphological features in small HCC are not yet fully understood. These issues are addressed here.

Methods: Histological examinations were conducted on 260 HCC nodules (< or =3 cm in diameter) which were surgically obtained from 249 patients. According to the distribution pattern, fatty changes were classified into two types: 'diffuse type' when the change was found throughout the cancerous nodule; and 'focal type' when the change was localized in part of the nodule. To study the pathogenesis of fatty change in HCC in relation to angioarchitecture, the number of arterial tumor vessels and intratumoral portal tracts in 104 of the 260 nodules was counted.

Results: Fatty change was found in 51 of the 260 nodules (19.6%), the frequency was highest (36.4%) in the nodules whose diameter was 1.1 to approximately 1.5 cm, and the frequency decreased with the increase in tumor diameter. Small well-differentiated HCCs were often associated with a diffuse type fatty change. With the increase in tumor diameter, moderately differentiated cancerous tissues without associated fatty change appeared, and the focal type was found more frequently. According to the angioarchitecture, in HCCs < or =1.5 cm, the number of intratumoral arteries was significantly smaller in HCCs with fatty change (p<0.05), though the number of intratumoral portal tracts was not significantly different compared with HCCs without fatty change.

Conclusion: These findings suggest that fatty change of small HCC is closely related to the tumor size, the histological grade and insufficient development of the arterial tumor vessels.

Citing Articles

A Nomogram Based on MRI Visual Decision Tree to Evaluate Vascular Endothelial Growth Factor in Hepatocellular Carcinoma.

Dai H, Yan C, Huang W, Pan Y, Pan F, Liu Y J Magn Reson Imaging. 2025; 61(2):970-982.

PMID: 39777758 PMC: 11706310. DOI: 10.1002/jmri.29491.


Advances in Understanding Hepatocellular Carcinoma Vasculature: Implications for Diagnosis, Prognostication, and Treatment.

Rhee H, Park Y, Choi J Korean J Radiol. 2024; 25(10):887-901.

PMID: 39344546 PMC: 11444852. DOI: 10.3348/kjr.2024.0307.


Nodule-in-nodule architecture of hepatocellular carcinomas: enhancement patterns in the hepatobiliary phase and pathological features.

Xing F, Ma Q, Lu J, Zhu W, Du S, Jiang J Abdom Radiol (NY). 2024; 49(11):3834-3846.

PMID: 38913136 DOI: 10.1007/s00261-024-04259-y.


Fat fraction quantification with MRI estimates tumor proliferation of hepatocellular carcinoma.

Huang M, Zhang F, Li Z, Luo Y, Li J, Wang Z Front Oncol. 2024; 14:1367907.

PMID: 38665944 PMC: 11044697. DOI: 10.3389/fonc.2024.1367907.


Liver Lesions at Risk of Transformation into Hepatocellular Carcinoma in Cirrhotic Patients: Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement.

Brandi N, Renzulli M J Clin Transl Hepatol. 2024; 12(1):100-112.

PMID: 38250460 PMC: 10794268. DOI: 10.14218/JCTH.2023.00130.